Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Prognostic value of a computer-aided diagnosis system involving bone scans among men treated with docetaxel for metastatic castration-resistant prostate cancer

Fig. 4

Kaplan–Meier curve for overall survival (OS) after docetaxel induction therapy according to the bone scan index (BSI). The blue line indicates survival for patients with a BSI ≤1 (n = 18) and the red line indicates survival for patients with a BSI >1 (n = 23). The median OS of patients with a BSI ≤1 and a BSI >1 was 26.5 and 15.4 months, respectively (p = 0.029)

Back to article page